SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-14-005281
Filing Date
2014-11-06
Accepted
2014-11-05 20:18:13
Documents
11
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q gff10q_110314.htm 10-Q 335155
2 EXHIBIT 10.1 exh_101.htm EX-10.1 75573
3 EXHIBIT 31.1 exh_311.htm EX-31.1 8687
4 EXHIBIT 31.2 exh_312.htm EX-31.2 8559
5 EXHIBIT 32.1 exh_321.htm EX-32.1 3294
  Complete submission text file 0001171843-14-005281.txt   3540394

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE anik-20140930.xml EX-101.INS 438171
7 XBRL SCHEMA FILE anik-20140930.xsd EX-101.SCH 45835
8 XBRL CALCULATION FILE anik-20140930_cal.xml EX-101.CAL 38838
9 XBRL DEFINITION FILE anik-20140930_def.xml EX-101.DEF 178502
10 XBRL LABEL FILE anik-20140930_lab.xml EX-101.LAB 253533
11 XBRL PRESENTATION FILE anik-20140930_pre.xml EX-101.PRE 181106
Mailing Address 32 WIGGINS AVENUE BEDFORD MA 01730
Business Address 32 WIGGINS AVENUE BEDFORD MA 01730 (781) 457-9000
Anika Therapeutics, Inc. (Filer) CIK: 0000898437 (see all company filings)

IRS No.: 043145961 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-14027 | Film No.: 141198468
SIC: 3841 Surgical & Medical Instruments & Apparatus
Industrial Applications and Services